Natures Sunshine Products INC 8-K filings

Natures Sunshine announced a 2% net sales increase to $117.0 million and a 194 basis point improvement in gross profit margin for Q2 2026, alongside the appointment of Ruth Perkins as EVP and CFO.

Natures Sunshine Products, Inc. announced the resignation of its CFO, L. Shane Jones, effective June 5, 2026, and the appointment of Jonathan D. Lanoy as interim Principal Financial Officer.

Nature's Sunshine reported a 9% increase in Q1 2026 net sales to $122.9 million and received shareholder approval for its 2026 Stock Incentive Plan.

Natures Sunshine Products reports strong third-quarter 2025 financial results with net sales up 12% to $128.3 million and a raised full-year outlook.

Natures Sunshine Products, Inc. announced the appointment of Kenneth Romanzi as its new Chief Executive Officer, succeeding Terrence O. Moorehead, effective October 29, 2025.

Nature's Sunshine Products, Inc. announced robust second-quarter 2025 financial results, featuring increased net sales and adjusted EBITDA, leading to an upward revision of its full-year guidance.

Nature's Sunshine Products, Inc. will acquire the remaining 20% interests in its Hong Kong and Shanghai joint ventures from Fosun Industrial for a total of $7 million in cash, following Fosun Pharma's reduction in its stake in Nature's Sunshine.

Nature's Sunshine Products, Inc. disclosed a secondary public offering of 2.85 million shares by Fosun Pharma USA, Inc., alongside a potential company share repurchase of up to $15 million.

Natures Sunshine Products, Inc. announced that President and CEO Terrence O. Moorehead will step down upon the appointment of a successor, while the company reaffirms its full-year 2025 financial outlook.

Natures Sunshine Products, Inc. announced a 2% increase in net sales and a 20% increase in adjusted EBITDA for the first quarter of 2025, along with a new share repurchase program.

Natures Sunshine Products, Inc. released its financial results for the fourth quarter and full year ended December 31, 2024, on March 11, 2025.

Nature's Sunshine Products' Compensation Committee approved salary increases for its CFO and EVP of Global Supply Chain, effective March 4, 2025.

Natures Sunshine Products has appointed Katie A. May to its Board of Directors and announced that Richard D. Moss will not stand for re-election at the upcoming annual shareholder meeting.

Nature's Sunshine Products reported a 3% increase in net sales for the third quarter of 2024, alongside the appointment of Steven J. Fasching to its Board of Directors.

Nature's Sunshine Products reported a 5% decrease in net sales and an 8% decrease in adjusted EBITDA for the second quarter of 2024, impacted by macroeconomic challenges and a temporary disruption in North America.

Nature's Sunshine Products reported a 2% increase in net sales and a significant rise in net income for the first quarter of 2024, fueled by strong digital growth and new product launches.

Nature's Sunshine Products reported a significant increase in net income and adjusted EBITDA for both the fourth quarter and full year 2023, driven by sales growth and cost optimization initiatives.

Natures Sunshine Products has increased the base salaries and incentive targets for its CEO, CFO, and Executive Vice President of Global Supply Chain.

Nature's Sunshine Products has amended its previous 8-K filing to specify that it will hold an annual advisory vote on executive compensation.